In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses why more cancer research is being done about de-escalation treatment, including how these types of studies help doctors personalize treatment plans for each patient.
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery.
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer.
Clinical trial matching programs help people with cancer find research studies they may be eligible for. Here, learn more about what types of search assistance are available and how to discuss them with your health care team.
Read about two studies presented at the 2023 Genitourinary Cancers Symposium, covering plant-based diets and prostate cancer and a promising combination treatment for metastatic castration-resistant prostate cancer.
Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
In this podcast, Dr. Norah Lynn Henry discusses research from the 2022 San Antonio Breast Cancer Symposium (SABCS), including studies on treating metastatic breast cancer, preventing breast cancer from developing, and pregnancy during survivorship.
In this podcast, Dr. Christopher Flowers discusses new research from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, including new treatments for non-Hodgkin lymphoma and models for predicting early disease progression.
Read research from the January 2023 session of the ASCO Plenary Series, which highlights a study evaluating a blood-based test to select treatment for advanced gastrointestinal stromal tumors (GISTs).
